Evidence map›Paper›PMID 41948456›Full record

ArticleMedComm2026

Dysfunctional Lipid-Induced Secretion of Glucagon-Like Peptide-2(GLP-2), but Not of Incretins Glucagon-Like Peptide-1(GLP-1)/Glucose-Dependent Insulinotropic Polypeptide(GIP), Promotes Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Onset and Progression Through Gut Barrier Disruption and Endotoxemia.

Giovanni Musso, Silvia Pinach, Alberto Mella, Franco De Michieli, Anna Calabrese, Deborah Trifiro, Giovanna Petrangolini, Maurizio Cassader, Filippo Mariano, Roberto Gambino

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Giovanni MussoMECAU Department San Luigi Gonzaga Hospital, Orbassano Turin Italy.ORCID https://orcid.org/0000-0002-8569-2872
Silvia PinachDepartment of Medical Sciences Città Della Salute e della Scienza Hospital University of Turin Torino Italy.
Alberto MellaDepartment of Nephrology Città Della Salute e della Scienza Hospital University of Turin Torino Italy.
Franco De MichieliDepartment of Medical Sciences Città Della Salute e della Scienza Hospital University of Turin Torino Italy.
Anna CalabreseMECAU Department San Luigi Gonzaga Hospital, Orbassano Turin Italy.
Deborah TrifiroMECAU Department San Luigi Gonzaga Hospital, Orbassano Turin Italy.
Giovanna PetrangoliniR & D Indena S.p.A. Milan Italy.
Maurizio CassaderDepartment of Medical Sciences Città Della Salute e della Scienza Hospital University of Turin Torino Italy.
Filippo MarianoDepartment of Nephrology Città Della Salute e della Scienza Hospital University of Turin Torino Italy.
Roberto GambinoDepartment of Medical Sciences Città Della Salute e della Scienza Hospital University of Turin Torino Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

endotoxemiaintestinal barrierLPSNF‐kBpostprandialsteatohepatitis

Identifiers

PMID41948456
PMCPMC13052185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.